lofexidine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, N; Brady, K; Cortese, B; Guille, C; King, C; McRae-Clark, A; Nunn, L; Ramakrishnan, V; Rogers, T | 1 |
1 trial(s) available for lofexidine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The impact of lofexidine on stress-related opioid craving and relapse: Design and methodology of a randomized clinical trial.
Topics: Analgesics, Opioid; Clonidine; COVID-19; Craving; Humans; Hypothalamo-Hypophyseal System; Pandemics; Pituitary-Adrenal System; Recurrence; SARS-CoV-2 | 2021 |